Selected research
Industry Research
Lidocaine Transdermal Patch Industry Research Report 2026
Market perspective
The global Lidocaine Transdermal Patch market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lidocaine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lidocaine Transdermal Patch is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lidocaine Transdermal Patch is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lidocaine Transdermal Patch include Teva Pharmaceutical, Tide Pharmaceutical (SINO BIOPHARM), Mylan, Teikoku, Sorrento Therapeutics, Par Pharmaceutical, Hisamitsu and Endo International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lidocaine Transdermal Patch market in terms of revenue (US$ million) and, where applicable, sales volume (m pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lidocaine Transdermal Patch Market by Company
Teva Pharmaceutical
Tide Pharmaceutical (SINO BIOPHARM)
Mylan
Teikoku
Sorrento Therapeutics
Par Pharmaceutical
Hisamitsu
Endo International
Lidocaine Transdermal Patch Segment by Type
Lidocare 1.80% Transdermal Patch
Lidocare 5% Transdermal Patch
Lidocare 4% Transdermal Patch
Lidocaine Transdermal Patch Segment by Application
Clinic
Hospital Pharmacies
Online Pharmacies
Chain Pharmacies
Monomer Pharmacies
Other
Lidocaine Transdermal Patch Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lidocaine Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lidocaine Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lidocaine Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lidocaine Transdermal Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lidocaine Transdermal Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lidocaine Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lidocare 1.80% Transdermal Patch
- Lidocare 5% Transdermal Patch
- Lidocare 4% Transdermal Patch
Applications
- Clinic
- Hospital Pharmacies
- Online Pharmacies
- Chain Pharmacies
- Monomer Pharmacies
- Other
Companies covered
- Teva Pharmaceutical
- Tide Pharmaceutical (SINO BIOPHARM)
- Mylan
- Teikoku
- Sorrento Therapeutics
- Par Pharmaceutical
- Hisamitsu
- Endo International
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lidocaine Transdermal Patch Market Size (2021-2032)
- 2.2.2 Global Lidocaine Transdermal Patch Sales (2021-2032)
- 2.2.3 Global Lidocaine Transdermal Patch Market Average Price (2021-2032)
- 2.3 Lidocaine Transdermal Patch by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Lidocare 1.80% Transdermal Patch
- 2.3.3 Lidocare 5% Transdermal Patch
- 2.3.4 Lidocare 4% Transdermal Patch
- 2.4 Lidocaine Transdermal Patch by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital Pharmacies
- 2.4.4 Online Pharmacies
- 2.4.5 Chain Pharmacies
- 2.4.6 Monomer Pharmacies
- 2.4.7 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lidocaine Transdermal Patch Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lidocaine Transdermal Patch Sales (m pcs) of Manufacturers (2021-2026)
- 3.3 Global Lidocaine Transdermal Patch Revenue of Manufacturers (2021-2026)
- 3.4 Global Lidocaine Transdermal Patch Average Price by Manufacturers (2021-2026)
- 3.5 Global Lidocaine Transdermal Patch Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lidocaine Transdermal Patch, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lidocaine Transdermal Patch, Product Type & Application
- 3.8 Global Manufacturers of Lidocaine Transdermal Patch, Established Date
- 3.9 Global Lidocaine Transdermal Patch Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical
- 4.1.1 Teva Pharmaceutical Company Information
- 4.1.2 Teva Pharmaceutical Business Overview
- 4.1.3 Teva Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
- 4.1.5 Teva Pharmaceutical Recent Developments
- 4.2 Tide Pharmaceutical (SINO BIOPHARM)
- 4.2.1 Tide Pharmaceutical (SINO BIOPHARM) Company Information
- 4.2.2 Tide Pharmaceutical (SINO BIOPHARM) Business Overview
- 4.2.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolio
- 4.2.5 Tide Pharmaceutical (SINO BIOPHARM) Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Lidocaine Transdermal Patch Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Teikoku
- 4.4.1 Teikoku Company Information
- 4.4.2 Teikoku Business Overview
- 4.4.3 Teikoku Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teikoku Lidocaine Transdermal Patch Product Portfolio
- 4.4.5 Teikoku Recent Developments
- 4.5 Sorrento Therapeutics
- 4.5.1 Sorrento Therapeutics Company Information
- 4.5.2 Sorrento Therapeutics Business Overview
- 4.5.3 Sorrento Therapeutics Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolio
- 4.5.5 Sorrento Therapeutics Recent Developments
- 4.6 Par Pharmaceutical
- 4.6.1 Par Pharmaceutical Company Information
- 4.6.2 Par Pharmaceutical Business Overview
- 4.6.3 Par Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
- 4.6.5 Par Pharmaceutical Recent Developments
- 4.7 Hisamitsu
- 4.7.1 Hisamitsu Company Information
- 4.7.2 Hisamitsu Business Overview
- 4.7.3 Hisamitsu Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hisamitsu Lidocaine Transdermal Patch Product Portfolio
- 4.7.5 Hisamitsu Recent Developments
- 4.8 Endo International
- 4.8.1 Endo International Company Information
- 4.8.2 Endo International Business Overview
- 4.8.3 Endo International Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Endo International Lidocaine Transdermal Patch Product Portfolio
- 4.8.5 Endo International Recent Developments
5 Global Lidocaine Transdermal Patch Market Scenario by Region
- 5.1 Global Lidocaine Transdermal Patch Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lidocaine Transdermal Patch Sales by Region: 2021-2032
- 5.2.1 Global Lidocaine Transdermal Patch Sales by Region: 2021-2026
- 5.2.2 Global Lidocaine Transdermal Patch Sales by Region: 2027-2032
- 5.3 Global Lidocaine Transdermal Patch Revenue by Region: 2021-2032
- 5.3.1 Global Lidocaine Transdermal Patch Revenue by Region: 2021-2026
- 5.3.2 Global Lidocaine Transdermal Patch Revenue by Region: 2027-2032
- 5.4 North America Lidocaine Transdermal Patch Market Facts & Figures by Country
- 5.4.1 North America Lidocaine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lidocaine Transdermal Patch Sales by Country (2021-2032)
- 5.4.3 North America Lidocaine Transdermal Patch Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Lidocaine Transdermal Patch Market Facts & Figures by Country
- 5.5.1 Europe Lidocaine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lidocaine Transdermal Patch Sales by Country (2021-2032)
- 5.5.3 Europe Lidocaine Transdermal Patch Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Lidocaine Transdermal Patch Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lidocaine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lidocaine Transdermal Patch Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lidocaine Transdermal Patch Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lidocaine Transdermal Patch Market Facts & Figures by Country
- 5.7.1 South America Lidocaine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lidocaine Transdermal Patch Sales by Country (2021-2032)
- 5.7.3 South America Lidocaine Transdermal Patch Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Lidocaine Transdermal Patch Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lidocaine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lidocaine Transdermal Patch Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lidocaine Transdermal Patch Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Lidocaine Transdermal Patch Sales by Type (2021-2032)
- 6.1.1 Global Lidocaine Transdermal Patch Sales by Type (2021-2032) & (m pcs)
- 6.1.2 Global Lidocaine Transdermal Patch Sales Market Share by Type (2021-2032)
- 6.2 Global Lidocaine Transdermal Patch Revenue by Type (2021-2032)
- 6.2.1 Global Lidocaine Transdermal Patch Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lidocaine Transdermal Patch Revenue Market Share by Type (2021-2032)
- 6.3 Global Lidocaine Transdermal Patch Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lidocaine Transdermal Patch Sales by Application (2021-2032)
- 7.1.1 Global Lidocaine Transdermal Patch Sales by Application (2021-2032) & (m pcs)
- 7.1.2 Global Lidocaine Transdermal Patch Sales Market Share by Application (2021-2032)
- 7.2 Global Lidocaine Transdermal Patch Revenue by Application (2021-2032)
- 7.2.1 Global Lidocaine Transdermal Patch Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lidocaine Transdermal Patch Revenue Market Share by Application (2021-2032)
- 7.3 Global Lidocaine Transdermal Patch Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lidocaine Transdermal Patch Value Chain Analysis
- 8.1.1 Lidocaine Transdermal Patch Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lidocaine Transdermal Patch Production Mode & Process
- 8.2 Lidocaine Transdermal Patch Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lidocaine Transdermal Patch Distributors
- 8.2.3 Lidocaine Transdermal Patch Customers
9 Global Lidocaine Transdermal Patch Analyzing Market Dynamics
- 9.1 Lidocaine Transdermal Patch Industry Trends
- 9.2 Lidocaine Transdermal Patch Industry Drivers
- 9.3 Lidocaine Transdermal Patch Industry Opportunities and Challenges
- 9.4 Lidocaine Transdermal Patch Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst